Medvarsity Logo
Male Infertility: The Silent Shame

CASE DISCUSSION

Male Infertility: The Silent Shame

India flagPresented India by Dr. Richika Sahay

Views

9,717

Case Description

Male infertility, often relegated to the shadows of conversation, is a pervasive yet frequently overlooked issue causing immense emotional distress and societal stigma. The silence surrounding this topic stems from cultural taboos and misconceptions, leaving many men to grapple with feelings of...

Case Summary

  • The presentation discusses male infertility, highlighting that it accounts for a significant percentage of infertility cases worldwide, with variations across different regions. The process of spermatogenesis is explained in detail, emphasizing the time required for mature sperm formation and the importance of understanding different stages like spermatogonia, spermatocytes, and spermatids for diagnosis through FNAC of the testis. Endocrine control of spermatogenesis is also covered, outlining the roles of the central nervous system, hypothalamus, pituitary gland, and Leydig and Sertoli cells in hormone production and sperm development.

Speaker Profile

Dr. Richika Sahay

Dr. Richika Sahay

Alumni- MGM Medical College
Dr. Richika Sahay is a leading fertility specialist and Gynec-Laparoscopic Surgeon with extensive experience in reproductive medicine and women’s health. She serves as the Director at India IVF Clinic and is also associated with Fortis Hospital as Head Fertility Specialist and Gynec-Laparoscopic Surgeon. Her expertise includes infertility management, IVF treatments, reproductive endocrinology, and minimally invasive gynecological surgeries. She is dedicated to providing personalized, evidence-based fertility care focused on improving reproductive outcomes for couples. Through her clinical practice and leadership roles, she continues to contribute to advancements in assisted reproductive technologies and women’s healthcare.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.